Summit Therapeutics EBITDA 2015-2025 | SMMT
- Summit Therapeutics 2024 EBITDA was -0.226B, a 62.93% decline from 2023.
- Summit Therapeutics 2023 EBITDA was -0.609B, a 775.96% increase from 2022.
- Summit Therapeutics 2022 EBITDA was -0.07B, a 16.91% decline from 2021.
EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.